Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Sugammadex and the Diaphragm: Recovery of Diaphragmatic Function and Neuromuscular Blockade. A Double-blind Randomized Controlled Trial

NCT01962298 is registered in ClinicalTrials.gov with University Hospital, Antwerp as lead sponsor.

NCT NCT01962298
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01962298 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Sugammadex and the Diaphragm: Recovery of Diaphragmatic Function and Neuromuscular Blockade. A Double-blind Randomized Controlled Trial
Lead sponsor
University Hospital, Antwerp
Phase
Phase 3
Overall status
Completed
Start date
October 31, 2013
Completion date
December 31, 2014
Enrollment
75 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diaphragmatic dysfunction, muscle fatigue, muscle weakness